Literature DB >> 10835064

Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE).

R J Hogg1, R J Portman, D Milliner, K V Lemley, A Eddy, J Ingelfinger.   

Abstract

OBJECTIVE: The development of this review article evolved from a National Kidney Foundation consensus conference on recent advances in the importance of evaluating and treating proteinuria. From this conference, a series of recommendations for the evaluation of adults with proteinuria was published. Because specific pediatric aspects of the problem were outside the scope of the original National Kidney Foundation publication, an ad hoc committee of 6 pediatric nephrologists who were active participants in the National Kidney Foundation conference was established to provide primary care physicians with a concise, up-to-date reference on this subject.
METHODS: The recommendations that are given represent the consensus opinions of the authors. These are based on data from controlled studies in children when available, but many of the opinions are, by necessity, based on uncontrolled series in children or controlled trials performed in adults, because controlled trials in children have not been performed to evaluate many of the treatments described. RESULTS AND
CONCLUSIONS: These recommendations are intended to provide primary care physicians with a useful reference when they are faced with a young child or teenager who presents with proteinuria, whether this is mild and asymptomatic or more severe, leading to nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10835064     DOI: 10.1542/peds.105.6.1242

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  86 in total

1.  Vertebral fractures despite normal spine bone mineral density in a boy with nephrotic syndrome.

Authors:  Anne Marie Sbrocchi; Frank Rauch; MaryAnn Matzinger; Janusz Feber; Leanne M Ward
Journal:  Pediatr Nephrol       Date:  2010-10-05       Impact factor: 3.714

Review 2.  Management of proteinuria in the transplanted patient.

Authors:  Tomáš Seeman
Journal:  Pediatr Nephrol       Date:  2014-08-27       Impact factor: 3.714

Review 3.  Hematuria and Proteinuria in Children.

Authors:  Bernarda Viteri; Jessica Reid-Adam
Journal:  Pediatr Rev       Date:  2018-12

4.  Circannual variation in the onset and relapse of steroid-sensitive nephrotic syndrome.

Authors:  Shin-ichi Toyabe; Makiko Nakamizo; Makoto Uchiyama; Kouhei Akazawa
Journal:  Pediatr Nephrol       Date:  2005-02-18       Impact factor: 3.714

5.  Pediatric reference intervals for random urine calcium, phosphorus and total protein.

Authors:  Patricia R Slev; Ashley M Bunker; William E Owen; William L Roberts
Journal:  Pediatr Nephrol       Date:  2010-05-16       Impact factor: 3.714

6.  Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study.

Authors:  Omar Niss; Adam Lane; Monika R Asnani; Marianne E Yee; Ashok Raj; Susan Creary; Courtney Fitzhugh; Prasad Bodas; Santosh L Saraf; Sharada Sarnaik; Prasad Devarajan; Punam Malik
Journal:  Blood Adv       Date:  2020-04-14

7.  Renal complications of lipodystrophy: A closer look at the natural history of kidney disease.

Authors:  Baris Akinci; Sadiye Mehtat Unlu; Ali Celik; Ilgin Yildirim Simsir; Sait Sen; Banu Nur; Fatma Ela Keskin; Basak Ozgen Saydam; Nilufer Kutbay Ozdemir; Banu Sarer Yurekli; Bekir Ugur Ergur; Melda Sonmez; Tahir Atik; Atakan Arslan; Tevfik Demir; Canan Altay; Ulku Aybuke Tunc; Tugba Arkan; Ramazan Gen; Erdal Eren; Gulcin Akinci; Aslihan Arasli Yilmaz; Habib Bilen; Samim Ozen; Aygul Celtik; Senay Savas Erdeve; Semra Cetinkaya; Huseyin Onay; Sulen Sarioglu; Elif Arioglu Oral
Journal:  Clin Endocrinol (Oxf)       Date:  2018-05-17       Impact factor: 3.478

8.  Randomized, double-blind, controlled study of losartan in children with proteinuria.

Authors:  Nicholas J A Webb; Chun Lam; Tom Loeys; Shahnaz Shahinfar; Juergen Strehlau; Thomas G Wells; Emanuela Santoro; Denise Manas; Gilbert W Gleim
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

9.  Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).

Authors:  Yuko Shima; Koichi Nakanishi; Mayumi Sako; Mari Saito-Oba; Yuko Hamasaki; Hiroshi Hataya; Masataka Honda; Koichi Kamei; Kenji Ishikura; Shuichi Ito; Hiroshi Kaito; Ryojiro Tanaka; Kandai Nozu; Hidefumi Nakamura; Yasuo Ohashi; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2018-10-03       Impact factor: 3.714

Review 10.  Minimal Change Disease.

Authors:  Marina Vivarelli; Laura Massella; Barbara Ruggiero; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.